Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in the “Cover letter”).
  • Cover letter (you should upload your cover letter at “Cover letter” section of the online submission process)
  • The main manuscript (including title, abstract, text, acknowledgments, conflict of interest disclosure, references, tables and legends for figures) is in Microsoft Word (save the text file in .RTF, .DOC or .DOCX format only)
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines
  • References adhere to the requirements outlined in the Author Guidelines, for papers with more than three authors only the first three Authors must be indicated, followed by et al.
  • Where available, DOI numbers (with relative URLs) for the references have been provided.
  • Images are in .TIFF or .JPEG format, resolution at least 300 dpi (upload in separate files, see Author Guidelines for details. IMPORTANT: maximum dimension for each single file/image is 2 MB). Authors should provide colour images when available.
  • The Authorship responsibility - Financial disclosure- Copyright Transfer Form is properly filled in, signed, saved in .pdf format and uploaded in the next step of the submission process.

Author Guidelines

Information for Authors including editorial standards for the preparation of manuscripts


Pathologica is intended to provide a medium for the communication of results and ideas in the field of morphological research on human diseases in general and on human pathology in particular. The journal welcomes contributions concerned with experimental morphology, ultrastructural research, immunocytochemical analysis, and molecular biology. Reports of work in other fields relevant to the understanding of human pathology may be submitted as well all papers on the application of new methods and techniques in pathology.


The official language of the journal is English.


Manuscripts must be prepared in accordance with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” developed by the international committee of medical journal editors (http://www.icmje.org).


Authors need to register with the journal (LINK SITO PATHOLOGICA) prior to submitting their article via the online submission platform (OJS) or, if already registered, can simply log in and begin the five-step process.
Texts must be original and should not be presented simultaneously to more than one journal.


All scientific papers are published in English (British spelling and grammar) with title, abstract and key words. The text will be submitted to English language review by the publisher at no costs to the Authors. The Editor reserves the right to refuse any article not written in an appropriate English style.


Only papers strictly adhering to the editorial instructions outlined herein will be considered for publication. Acceptance is upon the critical assessment by experts in the field (Reviewers), the introduction of any changes requested and the final decision of the Editor-in-Chief.


Submission implies that publication has been approved by all co-authors, as well as, by the director of the Institute or Department where the work has been carried out.


After submission, you will receive a confirmation of receipt of your manuscript via OJS. You can also check the status of your manuscript on OJS. The editorial staff will inform you via OJS once a decision has been made.


Permissions.


Authorship responsibility - Financial disclosure- Copyright Transfer Form should be completed and signed by the Corresponding Author who accepts direct responsibility for the manuscript in agreement with all authors. It is not the role of editors to make authorship/contributorship decisions or to arbitrate conflicts related to authorship. The signed form can be electronically uploaded on OJS. Accepted papers will not be sent for publication until this form has been completed and submitted. The journal holds literary rights to printed articles.
Every Author or co-Author of any article published in this Journal is solely responsible for the contents of the article and for the statements made in their paper, and must specify that consent has been obtained from patients taking part in the investigations - or, in the case of paediatric patients, the guardian/s - and for the reproduction of any photographs and for the material sent. Every Author or co-Author needs to fully comply with the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation): «Article 9. Processing of personal data revealing racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, and the processing of genetic data, biometric data for the purpose of uniquely identifying a natural person, data concerning health or data concerning a natural person's sex life or sexual orientation shall be prohibited».
Written permission from the Authors to reproduce any material with copyright elsewhere must be obtained prior to submission. Authors must state that the material submitted has not been previously published, and is not under consideration (in whole or in part) elsewhere, and that it conforms with regulations currently in force regarding research ethics. For studies performed on laboratory animals, the Authors must state that the relevant national laws or institutional guidelines have been adhered to. If an experiment on humans is described, a statement must be included that the work was performed in accordance with the principles of the 1983 Declaration of Helsinki. In this case, the research should have the approval of the relevant local ethical review body and such approval must be explicitly mentioned in the manuscript. Authors must state any information that may be perceived as potential conflict of interest. They should declare whether they have obtained other forms of personal or institutional financing - or if they are under contract - from Companies manufacturing products mentioned in the article. This declaration will be treated by the Editor as confidential while the paper is under review, and will not be made known to Reviewers. Such conflicts/financial supports must be specified both in the authorship form AND in the main manuscript, in a specific session entitled “CONFILCT OF INTEREST/FINANCIAL DISCLOSURE” at the end of the manuscript, before references. Accepted articles must include a declaration stating the source and nature of financing.


Privacy Policy Statement.


Personal data of the Author will be managed by the Publisher in full compliance with the current legislation on the privacy protection (art. 13 of EU regulation 2016/6799).


According to articles 15-20 of the GDPR, any Author may exercise specific rights, including the right to obtain access to personal data in an intelligible form, correct, update or cancel them. Authors will also have the right to obtain from the Publisher limitation of data processing, and may also oppose to data processing legitimate reasons. In the case that the Author believes that processing of his/her own personal data infringes the of GDPR regulation, he/she has the right to make a complaint to the Supervisory Authority for the Protection of Personal Data according to art. 77 of the GDPR. Controller of data processing, according to art. 4.1.7 of the GDPR, is Mrs. Donatella Paoletti for Pacini Editore Srl, with registered office in 56121 Pisa, Italy, Via A Gherardesca n. 1. To exercise the rights of GDPR referred to in paragraph 6 of the same article, you can address any request for information to the following e-mail: privacy@pacinieditore.it. For further information refer to the website: http://www.pacinieditore.it/privacy/ (nuova frase GDPR, ndr.)



Article categories and manuscripts format


Pathologica publishes the types of articles defined below. When submitting your manuscript, please follow the instructions relevant to the applicable article category. Your manuscript will be returned to you if it does not meet these criteria.


Original articles. Original articles are full-length original reports of clinical or basic science data, which has not yet been published, that cover topics in the field of morphological research on human diseases in general and on human pathology in particular. and that represent advanced information and a new contribution to biomedical literature. Article types include, but are not limited to: clinical trials, cohort studies, case-control studies, cross-sectional surveys and diagnostic test assessments. An emphasis is given for higher levels of evidence.
Text should be arranged as follows: title (not longer than 100 characters spaces included), abstract, key words, main text (Introduction, Materials and methods [If present, the type of statystical analysis should ALWAYS be specified in the Materials and methods section], Results, Discussion, Conclusions, Acknowledgments, Conflict of interest disclosure (including eventual fundings), References, Tables and Figure legends. Text should not exceed 40.000 characters including spaces.
- The first page should specify type of article (original contribution, etc.) and if it is a clinical trial, cohort study, etc. and should contain the following: (1) A concise and informative title not exceeding 100 characters including spaces. (Subtitles should be avoided). (2) Running title not exceeding 100 characters including spaces. (3) The Authors’ full first names and surnames. (4) Name and address of the Institute or Institutes where the work was carried out; if the Authors are affiliated with different Institutes, the first Author and any others from the same Institute should be indicated with 1, the names of the Authors from another Institute with 2, and so on. (5) Name (written in full), surname and address of the corresponding Author, including telephone, fax numbers and e-mail address, to whom galley proofs are to be addressed. (6) Key words (max. 5).
- The abstract (no longer than 300 words) should be clear and concise. The abstract should be unstructured (without headings). It should include an outline of the problem, method of study, results and significance of the research.
Save the text file in .RTF, .DOC or .DOCX format only. Do not format the text in any way (avoid styles, borders, shading...); use only character styles such as italics, bold, underlined. Do not send the text in PDF. Notes to the text, indicated by asterisks or similar symbols, should appear at the bottom of the relevant page. Mathematical terms and formulae, abbreviations, and units of measure should conform to the standards set out in Science 1954;120:1078. Define acronyms at first mention in the text. Drugs should be referred to by their chemical name; the commercial name should be used only when absolutely unavoidable (capitalizing the first letter of the product name and giving the name of the pharmaceutical firm manufacturing the drug, town and country).


- Acknowledgements and mention of any grants or other forms of financial support should appear at the end of the paper, before the list of references. Even in case of no funding sources/conflict of interest, please specify it in this section.


- References should be limited to the most essential and relevant and NOT EXCEED 30 references, published allegedly in the last decade, identified in the text with numerals with numbers between (parenthesis) and in superscript, and listed at the end of the manuscript in the order in which they are cited. The titles of journals should be abbreviated according to the style used in the list of Journals Indexed for MEDLINE. For papers with more than three authors only the first three Authors must be indicated, followed by et al.
DOI NUMBER MUST BE INCLUDED WITH EACH REFERENCE (when available).


Examples of the correct format for citation of references:
Journal article: Oh EJ, Lee S, Bae JS, et al. TERT Promoter mutation in an aggressive cribriform morular variant of papillary thyroid carcinoma. Endocr Pathol 2017;28:49-53. doi: 10.1007/s12022-016-9454-3.
Books: Taussig MJ. Processes in pathology and microbiology. Oxford: Blackwell 1984.
Chapters from books: Vaughan MK. Pineal peptides: an overview. In Reiter RJ, ed. The pineal gland. New York: Raven 1984:39-81..


- Tables should be limited in number of 5. See below for details.
- Figures should be limited in number of 5. See below for details.


Systematic review (including meta-analysis): manuscripts should review topics of contemporary interest and importance. Reviews ideally should address controversial issues by expressing all different points of view. Critical assessments of literature and data sources in the field of morphological research on human diseases in general and on human pathology in particular are required. The review should be comprehensive and authoritative as reflected by a contemporary bibliography. Reviews must not exceed a total of 50.000 characters including spaces (including references, figure legends or tables). The review should not exceed 100 references. Authors are also required to include no more than 10 figures and/or tables (see below for details).
The components of a review article are: (1) A concise and informative title not exceeding 100 characters including spaces. (Subtitles should be avoided). (2) Running title not exceeding 100 characters including spaces. (3) The Authors’ full first names and surnames. (4) Name and address of the Institute or Institutes where the work was carried out; if the Authors are affiliated with different Institutes, the first Author and any others from the same Institute should be indicated with 1, the names of the Authors from another Institute with 2, and so on. (5) Name (written in full), surname and address of the corresponding Author, including telephone, fax numbers and e-mail address, to whom galley proofs are to be addressed. (6) Key words.
The abstract (no longer than 300 words) should be clear and concise. The abstract should be unstructured (without headings).
The introduction should outline explicitly the clinical problem and rationale for conducting the review. Review articles should not require a Materials/Methods or Results section. Furthermore we recommend, particularly for meta-analyses a Methods section that specifies the information sources and search strategy, inclusion and exclusion criteria, and potential biases in the review process, and a Results section that describes study selection, characteristics and statistical methods for summarizing data. Discussion should interpret results in light of the total available evidence. The Conclusion is to summarize key findings.


Editorials express opinions on current topics of interest. They are nearly always solicited by the Editor-in-Chief or by the members of the Editorial Board, although unsolicited editorials may occasionally be considered. Editorials may provide a commentary on an article in the issue of the Journal in which they appear or published elsewhere. Editorials are limited to 8.000 characters including spaces with at least 10 references. They may include 1-2 figures or tables (see below for details). They should have no more than 2 authors.


Letters to the Editor-in-Chief should be directed to the Editor-in-Chief regarding published material or information of timely interest and particularly if controversy exists. They should be brief and not exceed 8.000 characters including spaces, with no more than 10 references, and only 1 figure and/or table (see below for details). If the letter is related to a previously published article in Pathologica, it must be submitted within 6 months of publication. Letters commenting papers are sent to the authors of those papers for a response.


Case reports will be considered for publication only if they describe relevant cases (rare, of particular didactic interest, etc.). The clinical and pathologic data should be complete, using up-date methodology, and top-level images. The text should include a brief review of relevant references and a discussion on new data regarding the pathogenesis and/or the diagnostic role of pathology regarding the described case/disease. Submissions must have a title, an unstructured abstract and key words. Manuscript length: no more than 15.000 characters including spaces, 5 references, and a total of 5 original and quality figures and/or tables (see below for details).


Special sections: Guidelines and Reccomendations, Proceedings, “Pathologica storica”, Study Groups.


- Tables should be typewritten and numbered consecutively with Roman numerals. The same data should not be presented twice, both in the text and tables. Each table should have above a brief title and be self-explanatory and be cited in the text (Table I, Table II, etc.). The table should be supplement the material in the text rather than duplicate. Insert any notes below. Explain all the abbreviations.


- Figures should be uploaded in separate files. Do not include the figures in the text file but only cite them, numbered consecutively with Arabic numerals (Fig. 1, Fig. 2, etc.) in the text file. Figure legends should be indicated at the end of the text file and allow the reader to understand the figures without reference to the text. All symbols used in figures should be explained. Remove any information that can identify a patient. Software and format: preferably send images in .TIFF or .JPEG format, resolution at least 300 dpi (IMPORTANT: maximum dimension for each single file/image is 2 Mb). Insert an extension that identifies the file format (example: .TIFF; .JPEG). Authors are invited to send colour images which will be printed at no extra cost.


Submitting revisions: if the Authors are invited to submit a revised paper, they should re-submit it uploading it on OJS using password and username used to complete the first submission. Please re-name your manuscript as “Revised manuscript n…”.
-  Please include at the beginning of the same file a letter to reviewers describing the changes made point-by-point according to the reviewer’s comments.
-  Please be sure to upload all parts of the submission including main manuscript and figures.
-  Please ensure that you return your manuscript with the changes clearly marked (you can use the Track Changes function in Word or simply highlight where changes have been made).
-  Please during submission of the revised manuscript don’t delete the first and original version of your manuscript. 
If you need assistance please contact the Editorial office. Please in any correspondence provide the corresponding author’s name, title of the manuscript, manuscript number (very important) and a clear description of the problem.


After acceptance. Galley proofs will be sent via OJS to the corresponding author for final approval. The authors are required to carefully check the proofs and return them within 3 days of receipt. Substantial changes in title, authorship, affiliations, content, corrected values and references are not allowed without the approval of the Editor-in Chief. If the proofs are not received in time, the Authors will have to rely on the Editor's corrections only. The Authors are responsible for mistakes that have been overlooked. The date of receipt and the date of acceptance by the Scientific Committee will appear on each publication. The article may be published online first after receipt of the corrected proof. A pdf of all articles published are available in open access at (INSERIRE LINK SITO). Paper reprints will be provided only if requested by the authors and will be charged at extra cost.


Contact information.


Editorial Office: Pacini Editore srl, via A. Gherardesca 1, 56121 Pisa, Italy. For info: pathologica@pacinieditore.it


-------------------------------------------------------------------------


Pathologica is published every three months.


-------------------------------------------------------------------------


Coypright: Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology


Società Italiana di Anatomia Patologica e Citopatologia Diagnostica (SIAPEC-IAP) and Pacini Editore srl inform readers and users of the journal Pathologica that the published articles reflect only the research and the opinion of the authors signing the contents. These articles therefore do not represent and do not in any way constitute indications or guidelines of the SIAPEC-IAP itself. This differs from the texts and contents that are explicitly declared as official institutional matrix and published in the appropriate sections of the journal, which are dedicated to the Guidelines of SIAPEC-IAP.
The journal “Patologica” is sent to SIAPEC-IAP members, subscribers, doctors, health professionals, exclusively for professional training and improvement and to inform and promote activities and products / services, strictly related to the professional activities of users, always ensuring a strong affinity between the message and the user’s interest.
Please read the Privacy Policy at the following link: http://www.pacinimedicina.it/privacy-policy-informativa-privacy/.


For communications / information: info@pacinieditore.it


The Publisher remains at the complete disposal of those with rights whom it was impossible to contact, and for any omissions.

Pathologica - Journal of the Italian Society of Anatomic Pathology and Diagnostic Cytopathology, Italian Division of the International Academy of Pathology | Publisher: Pacini Editore Srl, Via Gherardesca 1, 56121 Ospedaletto (Pisa), Italy | E-mail: info@pacinieditore.it | Website: www.pacinimedicina.it | ISSN (online): 1591-951X